Contrave is a combination therapy consisting of naltrexone, an opioid antagonist, and bupropion, an aminoketone antidepressant. Results showed no statistically significant difference in the incidence ...

Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors. The U.S. no longer has the highest obesity rates in the world. It is now second to Mexico, according to a report ...

Yet another large-scale study testing the cardiovascular safety of the weight loss combination naltrexone-bupropion has been halted prematurely, TCTMD has confirmed. The trial, known as CONVENE, was ...

Contrived? Probably. But It’s called Contrave. Add another competitor to the list of recently introduced weight-loss drugs. Contrave is a combination of two old drugs — bupropion, an antidepressant, ...

SAN DIEGO, Nov. 25, 2013 /PRNewswire/ -- Orexigen Therapeutics, Inc. (Nasdaq: OREX) today announced successful results of the interim analysis of the Light Study. Based on these results, the Company ...

With rise obesity around the world there should have been a number of drugs to combat it. The reality is different. There are no safe and effective drugs in the market at present. Now one drug that ...

Orexigen's failure to keep a lid on a key safety analysis of its obesity drug Contrave led the Food and Drug Administration to force it to do a second study in order to prove that the medicine is safe ...